Biolocity 2025
Deadline: December 02, 2024
5 pm
Amount: There is no funding limit per project or a set number of projects that must be selected. All projects
and their budgets are evaluated on their own merit.
Purpose
BACKGROUND
Biolocity is a philanthropic, multi-institutional program that accelerates the commercialization of
early-stage medical technologies with intellectual property held at Emory University (Emory) and/or
Georgia Institute of Technology (GT). Biolocity provide a seamless continuum of resources that
uniquely enable Biolocity to create a robust and reproducible pipeline to grow innovations into
commercially viable products. Biolocity educates Product Developers to expedite the success (or
failure) of life science innovation to license or start up. Our established program at Emory and GT
consistently bridges academic technologies into the commercial realm.
Biolocity features three synergistic pillars: BiolocityU, Biolocity Fund, and Biolocity Launch to catalyze
medical technology commercialization. BiolocityU’s efforts focus on advancing understanding of life
science commercialization across a broad range of audiences: faculty, students, post-doctoral
trainees, and members of the community. These educational efforts interdigitate with Biolocity Fund
and Biolocity Launch.
ELIGIBILITY/REQUIREMENTS
Biolocity invites applications from principal investigators (PIs) who meet the following eligibility
criteria:
➢ Intellectual property rights must be held (at least in part) by one of our partner
institutions; Emory University and/or Georgia Institute of Technology
- To be considered, an invention disclosure must be submitted to Emory OTT or
GTRC OTL prior to pre-proposal submission.
➢ Teams having two PIs is preferred - one with expertise in the technical domain, the
other in the clinical setting.
- At least one PI must be an Emory or Georgia Tech faculty member.
➢ New applicants are strongly encouraged to attend the BiolocityU
Bench2Market Talks series.
EVALUATION CRITERIA
Technologies are evaluated based on the probability of future commercial success and the following
criteria:
- Validity of unmet clinical need
- Competitive landscape
- Current and future market dynamics
- Strength and nature of intellectual property
- Addressability of regulatory risk
- Understanding of potential reimbursement hurdles
- High probability clinical use or follow-on funding within 2-3 years of receiving an award
NEW Biolocity Application Process
- Submit Video & LOI: Submit a 3-5 minute lightning pitch video and letter of intent (LOI).
- OC Evaluation: The Biolocity Team and Oversight Committee (OC) review pitches and LOIs to select projects for the next phase.
- Invitation for Full Application: Selected projects are invited to submit a full application and present a full pitch to the OC.
- Bench2Market Talk: Watch a 1-hour Bench2Market Talk on crafting a compelling pitch to prepare milestone and budget documents.
- Milestone & Budget Review: Attend a review session for milestone and budget planning.
- Submit Full Proposal: Submit the completed full proposal.
- Pitch Coaching: Attend mandatory full-pitch coaching.
- Final Pitch: Present the full pitch to the OC.
LOI and lightning pitch must be submitted via Airtable by 5pm December 2, 2024.
More Info: www.biolocity.org